148 related articles for article (PubMed ID: 12083328)
41. [Clinical study of lamivudine and interferon combinate administration to inhibit hepatitis B virus replication].
Song JW; Zhang G; Lin JG; Tang WX; Lin JS
Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):593-6. PubMed ID: 15504288
[TBL] [Abstract][Full Text] [Related]
42. Core promoter mutations 3 years after anti-hepatitis B e seroconversion in patients with chronic hepatitis B or hepatitis B and C infection and cancer remission.
Zampino R; Marrone A; Karayiannis P; Cirillo G; del Giudice EM; Rania G; Utili R; Ruggiero G
Am J Gastroenterol; 2002 Sep; 97(9):2426-31. PubMed ID: 12358268
[TBL] [Abstract][Full Text] [Related]
43. Evolution of hepatitis B virus precore/basal core promoter gene in HBeAg-positive chronic hepatitis B patients receiving lamivudine therapy.
Lin CL; Liao LY; Wang CS; Chen PJ; Lai MY; Chen DS; Kao JH
Liver Int; 2004 Feb; 24(1):9-15. PubMed ID: 15101995
[TBL] [Abstract][Full Text] [Related]
44. Lamivudine treatment in HBeAg-negative chronic hepatitis B patients with low level viraemia.
Bozkaya H; Yurdaydin C; Idilman R; Tüzün A; Cinar K; Erkan O; Bozdayi AM; Erden E; Uzun Y; Cetinkaya H; Uzunalimoglu O
Antivir Ther; 2005; 10(2):319-25. PubMed ID: 15865226
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of viral replication in children with chronic hepatitis B with and without interferon treatment.
Lazăr C; Grigorescu-Sido P; Manasia R; Mireştean S; Skorka C; Neculoiu D; Molnar G; Cocean S
Rom J Gastroenterol; 2005 Sep; 14(3):219-24. PubMed ID: 16200230
[TBL] [Abstract][Full Text] [Related]
46. [Role of ribavirin in the treatment of chronic hepatitis B].
Galban García E; Vega Sánchez H; Gra Oramas B; Rodríguez Pérez A; Doval Hernández MA; Haedo Castro D; Rolo F; Lorenzo Morejón I; Ramos Sánchez V
Gastroenterol Hepatol; 2000 Apr; 23(4):165-9. PubMed ID: 10863856
[TBL] [Abstract][Full Text] [Related]
47. High doses of alpha-interferon are required in chronic hepatitis due to coinfection with hepatitis B virus and hepatitis C virus: long term results of a prospective randomized trial.
Villa E; Grottola A; Buttafoco P; Colantoni A; Bagni A; Ferretti I; Cremonini C; Bertani H; Manenti F
Am J Gastroenterol; 2001 Oct; 96(10):2973-7. PubMed ID: 11693335
[TBL] [Abstract][Full Text] [Related]
48. Therapy for chronic hepatitis B with lymphoblastoid interferon-alpha and levamisole.
Fattovich G; Giustina G; Brollo L; Guido M; Pontisso P; Noventa F; Alberti A
Hepatology; 1992 Nov; 16(5):1115-9. PubMed ID: 1427652
[TBL] [Abstract][Full Text] [Related]
49. Interferon-alpha and zidovudine combination therapy for chronic hepatitis B: results of a randomized, placebo-controlled trial.
Janssen HL; Berk L; Heijtink RA; ten Kate FJ; Schalm SW
Hepatology; 1993 Mar; 17(3):383-8. PubMed ID: 8444411
[TBL] [Abstract][Full Text] [Related]
50. Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B.
Erhardt A; Reineke U; Blondin D; Gerlich WH; Adams O; Heintges T; Niederau C; Häussinger D
Hepatology; 2000 Mar; 31(3):716-25. PubMed ID: 10706563
[TBL] [Abstract][Full Text] [Related]
51. Human lymphoblastoid and fibroblast interferon in the treatment of chronic hepatitis B.
Hayashi J; Noguchi A; Nakashima K; Hayashi S; Kashiwagi S; Mayumi T; Motomura M
Clin Ther; 1990; 12(1):12-21. PubMed ID: 2328524
[TBL] [Abstract][Full Text] [Related]
52. Assessment of iron metabolism in children with chronic hepatitis B -- prognostic factor in interferon alpha therapy.
Chrobot A; Chrobot AM; Szaflarska-Szczepanik A
Med Sci Monit; 2002 Apr; 8(4):CR269-73. PubMed ID: 11951069
[TBL] [Abstract][Full Text] [Related]
53. Treatment of chronic viral hepatitis type B with oral mucosal administration of natural human interferon alpha lozenges.
Caban J; Mossor-Ostrowska J; Zyrkowska-Bieda T; Zejc M; Janas-Skulina U; Cieśla A; Cummins JM; Georgiades JA
Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):229-35. PubMed ID: 8129566
[TBL] [Abstract][Full Text] [Related]
54. Interferon-alpha treatment of children with chronic hepatitis D virus infection: the Greek experience.
Dalekos GN; Galanakis E; Zervou E; Tzoufi M; Lapatsanis PD; Tsianos EV
Hepatogastroenterology; 2000; 47(34):1072-6. PubMed ID: 11020882
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of alpha interferon for the treatment of chronic hepatitis B infection in Christchurch.
Burt MJ; Ross AG; Schroeder BA; Chambers ST; Chapman BA
N Z Med J; 1996 May; 109(1021):162-4. PubMed ID: 8657367
[TBL] [Abstract][Full Text] [Related]
56. [Effect of IL-12 on IFN-gamma and IL-10 produced by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection during IFN-alpha treatment].
Wang S; Lin Y; Ma W; Zhang B; Qi S; Lan F
Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):116-9. PubMed ID: 11983129
[TBL] [Abstract][Full Text] [Related]
57. Therapy of acute and chronic viral hepatitis.
Hoofnagle JH
Adv Intern Med; 1994; 39():241-75. PubMed ID: 8140956
[TBL] [Abstract][Full Text] [Related]
58. Long-term results with interferon therapy in chronic type B hepatitis: a prospective randomized trial.
Mazzella G; Saracco G; Festi D; Rosina F; Marchetto S; Jaboli F; Sostegni R; Pezzoli A; Azzaroli F; Cancellieri C; Montagnani M; Roda E; Rizzetto M
Am J Gastroenterol; 1999 Aug; 94(8):2246-50. PubMed ID: 10445557
[TBL] [Abstract][Full Text] [Related]
59. Chronic hepatitis B virus in children in Israel: clinical and epidemiological characteristics and response to interferon therapy.
Neudorf-Grauss R; Bujanover Y; Dinari G; Broide E; Neveh Y; Zahavi I; Reif S
Isr Med Assoc J; 2000 Feb; 2(2):164-8. PubMed ID: 10804945
[TBL] [Abstract][Full Text] [Related]
60. Relationship between hepatitis B virus genotype B and C and response to interferon therapy in HBeAg positive chronic hepatitis B patients: A meta-analysis.
Kong LN; Qin B; Ma Q; Li L; Yao Y
J Gastroenterol Hepatol; 2014; 29(7):1387-95. PubMed ID: 24548048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
